FindTrial
Sign In

A multicenter, retrospective clinical study to screen prognostic markers for the efficacy of malignant tumors of the digestive system based on multi-omics techniques

A multicenter, retrospective clinical study to screen prognostic markers for the efficacy of malignant tumors of the digestive system based on multi-omics techniques

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079234
Enrollment
Unknown
Registered
2023-12-28
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive system carcinoma

Interventions

Trial group:none

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) in the first affiliated hospital and Project Cooperation sub-center of Zhengzhou University, patients with malignant tumors of the digestive system (esophageal, gastric, cardiac, intestinal, anal, anal, pancreatic, liver, oral cavity, tongue, gingival, laryngeal, gallbladder, bile duct) were diagnosed by pathology and imaging (2) complete clinical data; (3) receiving at least first-line antineoplastic therapy; (4) ECOG score at baseline was less than or equal to 2.

Exclusion criteria

Exclusion criteria: (1) double or multiple primary cancers; (2) follow-up information was missing or not available;

Design outcomes

Primary

MeasureTime frame
overall survival;Lymph node metastasis status;—

Countries

China

Contacts

Public ContactFeng Wang

No. 1 East Jianshe Road, Zhengzhou, Henan Province, China

zzuwangfeng@zzu.edu.cn+86 139 3824 4771

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026